Bibliografía del artículo
1.- Garofalo C and Surmacz E. Leptin and cancer, J Cell Physiol 207 (2006), 12–22.
2.- Garofalo C, Sisci D and E. Surmacz, Leptin interferes with the effects of the antiestrogen ICI 182,780 in MCF-7 breast cancer cells, Clin Cancer Res 10 (2004), 6466–6475.
3.- Chlebowski R.T, Aiello E, and McTiernan A. Weight loss in breast cancer patient management, J Clin Oncol 20 (2002), 1128–1143.
4.- Hu X, Juneja S.C, Maihle N.J and Cleary M.P. Leptin–a growth factor in normal and malignant breast cells and for normal mammary gland development, J Natl Cancer Inst 94 (2002), 1704–1711.
5.- Rochefort H. Cathepsin D in breast cancer: a tissue marker associated with metastasis, Eur J Cancer 28 (1992), 1780–1783.
6.- Zahid M, Kohli E, Saeed M, Rogan E. and Cavalieri E. The greater reactivity of estradiol-3,4-quinone vs estradiol-2,3- quinone with DNA in the formation of depurinating adducts: implications for tumor-initiating activity, Chem Res Toxicol 19 (2006), 164–172.
7.- Lavigne J.A, Helzlsouer K.J, Huang H.Y, Strickland P.T et al. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer, Cancer Res 57 (1997), 5493–5497.